Shenzhen Neptunus Interlong Bio-technique Company Limited
8329.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$154.38M
Close$
Share Statistics
| Market cap | $154.38 Million |
|---|---|
| Enterprise Value | $48.74 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.02 |
| Beta | -0.13 |
| Outstanding Shares | 1,678,000,000 |
Return
| Return on Equity | -7.54% |
|---|---|
| Return on Assets | -4.61% |
| Return on Invested Capital | 1.60% |
Valuation & Multiples
| P/E Ratio | -2.67 |
|---|---|
| PEG | 9.85 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.04 |
| Enterprise Value to EBIT | 4.15 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 2.19 |
| Debt to Equity | 0.16 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Shenzhen Neptunus Interlong Bio-technique Company Limited
1,321 employees
CEO: Feng Zhang Based in Shenzhen, People's Republic of China, Shenzhen Neptunus Interlong Bio-technique Company Limited and its subsidiaries are primarily engaged in the research, development, production, and sale of pharmaceuticals. The company also h...